NICE Medtech Innovation Briefing (MIB)
Download the official NICE Medtech Innovation Briefing (MIB) on the Urethrotech UCD® Catheter. This independent evaluation reviews clinical evidence (as of 2016), patient safety, and cost-effectiveness.
This independent NICE evaluation highlights:
-
The innovative integration of a guidewire into a standard Foley catheter
-
Potential to avoid costly and invasive second-line procedures (cystoscopy or suprapubic catheterisation)
-
Evidence of safe use with no adverse events in UK studies
-
Cost and resource savings for the NHS by reducing failed catheterisations and urethral trauma
The briefing provides clinical evidence, economic context, and expert commentary on the role of UCD® in managing difficult or failed catheterisations.